| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |